Up Next
-
8m 26sPart 3 | Session 8 SMART-CRT: Effects of AV Optimization on CRT Outcomes
-
10m 10s
-
22m 15s
-
11m 55sPart 3 | Session 11 SPIRIT-HCM: Quality of Life After SM in Obstructive Patients With HCM
-
16m 38sPart 1 | Session 1 AHA 2021 Late-breaker Discussion: The EMPULSE Trial
-
16m 2sPart 1 | Session 2 AHA 21 Late-breaker Discussion: The CHIEF-HF Clinical Trial
-
12m 12sPart 1 | Session 3 AHA 2021 Late-breaker Discussion: The Digital Care Transformation Study
-
9m 51s
-
5m 28sPart 3 | Session 1 Population Strategies for the Management of Hypertension
-
5m 41sPart 3 | Session 2 ROSE: CETPi Lowers LDL-C in Patients Taking High Intensity Statins
-
7m 58s
-
6m 56sPart 3 | Session 4 EAST-AFNET 4: Early Rhythm Control Was Consistent in AF Patterns
-
6m 35sPart 3 | Session 5 EMPEROR-Preserved: Empagliflozin, Health Status, & QoL in Patients With HFp
-
10m 20s
Overview
Our regular review series View from the Thoraxcenter hosted by Prof Nicolas Van Mieghem and Dr Joost Daemen provide a concise and insightful preview of the late-breaking science presented at AHA Scientific Sessions 2021.
For a deep-dive, watch Dr Harriette Van Spall's Late-breaking Discussion series on highly expected trials with principal investigators.
Short, accessible Expert Interviews will be available conducted with select faculty focusing on the results, applicability, and impact on future research.
More from this programme
Part 1
Late-breaker Discussion Series
Part 2
View from the Thoraxcenter: Preview of the Late-Breaking Trials
Part 3
